Author:
Brill Livnat,Rechtman Ariel,Zveik Omri,Haham Nitzan,Levin Netta,Shifrin Alla,Rozenberg Ayal,Vaknin-Dembinsky Adi
Subject
Neurology (clinical),Neurology,General Medicine
Reference30 articles.
1. Achiron A., Dolev M., Menascu S., et al. COVID-19 vaccination in patients with multiple sclerosis : what we have learnt by February 2021. Published online 2021:1–7. doi:10.1177/13524585211003476.
2. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021
3. Managing multiple sclerosis in the Covid19 era : a review of the literature and consensus report from a panel of experts in Saudi Arabia;Al;Mult. Scler. Relat. Disord.,2021
4. Both cladribine and alemtuzumab may effect MS via B-cell depletion;Baker;Neurol. Neuroimmunol. NeuroInflamm.,2017
5. Clinical and analytical performance of an automated serological test that identifies S1/S2-neutralizing IgG in COVID-19 patients semiquantitatively. Miller MB;Bonelli;J. Clin. Microbiol.,2020
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献